
Adalimumab for JIA-Associated Uveitis: 5-Year Follow-up

Draft Guidelines & Recommendations for Juvenile Idiopathic Arthritis
What Do JIA Patients Experience? A New Case Study from the ARP Practice Committee

Fulbright Scholar Researches Physical Activity in Swedish Children with Juvenile Idiopathic Arthritis

How Juvenile Idiopathic Arthritis Affects Patients, Families

Adalimumab + Methotrexate Effective for Uveitis in JIA

Rheumatologist Dr. Sandra Pagnussat Recalls Journey from Patient to Physician

New Genetic Loci Identified, Epigenome Explored in Juvenile Idiopathic Arthritis
